Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIVO BIO TECH vs SYNGENE INTERNATIONAL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VIVO BIO TECH SYNGENE INTERNATIONAL VIVO BIO TECH/
SYNGENE INTERNATIONAL
 
P/E (TTM) x 37.3 60.9 61.2% View Chart
P/BV x 1.2 7.4 15.6% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 VIVO BIO TECH   SYNGENE INTERNATIONAL
EQUITY SHARE DATA
    VIVO BIO TECH
Mar-21
SYNGENE INTERNATIONAL
Mar-22
VIVO BIO TECH/
SYNGENE INTERNATIONAL
5-Yr Chart
Click to enlarge
High Rs71700 10.2%   
Low Rs18508 3.5%   
Sales per share (Unadj.) Rs38.665.0 59.4%  
Earnings per share (Unadj.) Rs4.29.9 42.9%  
Cash flow per share (Unadj.) Rs8.417.6 47.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Avg Dividend yield %00.2 0.0%  
Book value per share (Unadj.) Rs30.680.1 38.2%  
Shares outstanding (eoy) m13.42400.80 3.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.29.3 12.4%   
Avg P/E ratio x10.561.2 17.2%  
P/CF ratio (eoy) x5.334.3 15.4%  
Price / Book Value ratio x1.57.5 19.3%  
Dividend payout %010.1 0.0%   
Avg Mkt Cap Rs m597242,091 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m867,181 1.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m51826,042 2.0%  
Other income Rs m11,084 0.1%   
Total revenues Rs m51927,126 1.9%   
Gross profit Rs m1787,098 2.5%  
Depreciation Rs m563,097 1.8%   
Interest Rs m37241 15.2%   
Profit before tax Rs m864,844 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29886 3.3%   
Profit after tax Rs m573,958 1.4%  
Gross profit margin %34.327.3 126.0%  
Effective tax rate %34.118.3 186.3%   
Net profit margin %11.015.2 72.2%  
BALANCE SHEET DATA
Current assets Rs m27122,059 1.2%   
Current liabilities Rs m21812,289 1.8%   
Net working cap to sales %10.137.5 27.0%  
Current ratio x1.21.8 69.1%  
Inventory Days Days0190 0.0%  
Debtors Days Days51,413,59871 72,252,404.8%  
Net fixed assets Rs m52432,923 1.6%   
Share capital Rs m1344,008 3.3%   
"Free" reserves Rs m27728,093 1.0%   
Net worth Rs m41132,101 1.3%   
Long term debt Rs m1475,315 2.8%   
Total assets Rs m79554,982 1.4%  
Interest coverage x3.321.1 15.9%   
Debt to equity ratio x0.40.2 215.3%  
Sales to assets ratio x0.70.5 137.5%   
Return on assets %11.87.6 154.1%  
Return on equity %13.812.3 112.1%  
Return on capital %22.113.6 162.3%  
Exports to sales %00-   
Imports to sales %026.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA6,967 0.0%   
Fx inflow Rs m1923,253 0.1%   
Fx outflow Rs m426,967 0.6%   
Net fx Rs m-2316,286 -0.1%   
CASH FLOW
From Operations Rs m1425,806 2.4%  
From Investments Rs m-228-6,115 3.7%  
From Financial Activity Rs m88-313 -28.1%  
Net Cashflow Rs m1-615 -0.2%  

Share Holding

Indian Promoters % 42.2 70.3 60.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 18.3 -  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.8 29.7 194.7%  
Shareholders   12,632 128,278 9.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VIVO BIO TECH With:   VA TECH WABAG    DELTA CORP    HEALTHCARE GLOBAL ENTER.    YAARII DIGITAL INTEGRATED    SANGHVI MOVERS    



Today's Market

Sensex Zooms 450 Points, Nifty Tops 17,800; FMCG and Realty Stocks Rally(10:30 am)

Asian share markets opened higher today as another round of weak US data provided a little hope that the Federal Reserve will temper its pace of interest rate hikes.